Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Lopez

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2020
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II studyViolaine Randrian, Antoine Adenis, Jérôme Desrame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical TrialRémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, et al.
Nature Aging|March 30, 2023
Human striatal glia differentially contribute to AD- and PD-specific neurodegenerationJinbin Xu, Huifangjie L Farsad, Yiran Hou, et al.
Medicine|March 3, 2020
Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patientsAnthony Lopez, Kazuto Harada, Hsiang-Chun Chen, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Medical Oncology (Northwood, London, England)|July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patientsDilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Targeted Oncology|December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialKazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)Mathias Brugel, Léa Letrillart, Camille Evrard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2020
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II studyViolaine Randrian, Antoine Adenis, Jérôme Desrame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical TrialRémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, et al.
Nature Aging|March 30, 2023
Human striatal glia differentially contribute to AD- and PD-specific neurodegenerationJinbin Xu, Huifangjie L Farsad, Yiran Hou, et al.
Medicine|March 3, 2020
Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patientsAnthony Lopez, Kazuto Harada, Hsiang-Chun Chen, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Medical Oncology (Northwood, London, England)|July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patientsDilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Targeted Oncology|December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialKazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)Mathias Brugel, Léa Letrillart, Camille Evrard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
Pageof 7